Connect with us

Hi, what are you looking for?

Friday, Sep 11, 2026

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "Novartis"

Scribe Therapeutics develops one-time cholesterol treatment without permanent gene editing

Scribe Therapeutics develops one-time cholesterol treatment without permanent gene editing

Medical and Pharmaceutical

Scribe Therapeutics develops one-time cholesterol treatment without permanent gene editing

Scribe instead wants one treatment to keep PCSK9 switched down for an extended period

Joseph MortonAugust 20, 2026

Novartis advances actinium-based cancer drug after promising trial data

Novartis advances actinium-based cancer drug after promising trial data

Medical and Pharmaceutical

Novartis advances actinium-based cancer drug after promising trial data

Researchers presented the findings at the annual meeting of the American Society of Clinical Oncology in Chicago

Joseph MortonJune 1, 2026

AI-designed drugs near human trials as AlphaFold enters clinical phase

AI-designed drugs near human trials as AlphaFold enters clinical phase

AI and Autonomy

AI-designed drugs near human trials as AlphaFold enters clinical phase

Isomorphic Labs launched in 2021 as a unit of Alphabet Inc

Joseph MortonApril 29, 2026

More Posts